Clinical Trial Update: Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating pancreatic parenchymal injection of N-butyl-2-cyanoacrylate for issues related to pancreaticoduodenectomy, including post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Periampullary Cancer
• Postoperative Pancreatic Fistula

Drugs mentioned

• N-butyl-2-cyanoacrylate (cyanoacrylate tissue adhesive)

Snippet

Sponsor: Minia University | Conditions: Pancreaticoduodenectomy, Postoperative Pancreatic Fistula | Phase 2 | Status: RECRUITING